Advertisement
Advertisement
BBOT
BridgeBio Oncology Therapeutics, Inc. Common Stock
4.16
USDSponsored
-0.50
-10.73%
Sep 23, 15:59 UTC -4
Closed
After-Market
4.30
+0.14
+3.37%
BridgeBio Oncology Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 344.75M |
| Beta | 0.38 |
| Earnings Per Share (EPS) | -2.76 |
| Price-to-Book (P/B) Ratio | 1.16 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -46.90% |
| Current Ratio | 4.69% |
| Free Cash Flow | -80.35M |
